Design and colour combination deemed ‘too common’ in the pharma sector for protection | Court says trademarks must be distinctive across the EU, not just individual countries.
In a wide-ranging interview, INTA’s president-elect and global head of trademarks for Sandoz, David Lossignol, talks about the challenges of managing pharmaceutical brand rights and the growing threat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback